Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 132,214,496
  • Shares Outstanding, K 534,200
  • Annual Sales, $ 25,979 M
  • Annual Income, $ 5,893 M
  • 60-Month Beta 0.58
  • Price/Sales 5.03
  • Price/Cash Flow 10.36
  • Price/Book 142.75
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 21.03% ( -0.80%)
  • Historical Volatility 19.60%
  • IV Percentile 26%
  • IV Rank 27.98%
  • IV High 30.77% on 04/26/22
  • IV Low 17.25% on 06/17/21
  • Put/Call Vol Ratio 0.42
  • Today's Volume 6,956
  • Volume Avg (30-Day) 6,237
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 142,645
  • Open Int (30-Day) 151,318

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 4.30
  • Number of Estimates 10
  • High Estimate 4.87
  • Low Estimate 2.97
  • Prior Year 4.38
  • Growth Rate Est. (year over year) -1.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
227.32 +9.55%
on 05/02/22
253.00 -1.57%
on 04/26/22
-1.31 (-0.52%)
since 04/22/22
3-Month
214.39 +16.16%
on 02/24/22
258.45 -3.64%
on 04/11/22
+28.04 (+12.69%)
since 02/23/22
52-Week
198.64 +25.37%
on 12/01/21
258.45 -3.64%
on 04/11/22
-1.97 (-0.78%)
since 05/21/21

Most Recent Stories

More News
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA

Novartis (NVS) Cosentyx gets a positive CHMP recommendation for the indication of juvenile idiopathic arthritis.

NVS : 90.71 (+1.44%)
GERN : 1.2700 (-4.51%)
AMGN : 249.04 (+0.62%)
ALKS : 29.30 (-2.33%)
Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?

J&J's immunology mega-blockbuster loses exclusivity in the U.S. next year -- and Amgen's biosimilar is ready to capitalize.

JNJ : 179.44 (+1.39%)
AMGN : 249.04 (+0.62%)
Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer

Mirati (MRTX) seeks a nod for its lung cancer candidate adagrasib in the European Union. A regulatory filing in the United States is currently under the FDA review with decision pending this year-end.

BMY : 76.70 (+0.67%)
MRK : 93.83 (+0.30%)
AMGN : 249.04 (+0.62%)
MRTX : 63.58 (+0.36%)
Radius (RDUS), Menarini Post Positive Data on Breast Cancer Drug

Radius (RDUS) and partner Menarini announce data from a late-stage study on breast cancer drug.

LLY : 302.60 (+1.25%)
AMGN : 249.04 (+0.62%)
ALKS : 29.30 (-2.33%)
RDUS : 6.04 (-3.36%)
2 Buy-Rated Dow Jones Stocks to Add to Your Portfolio Now

Investors’ concerns over a potential recession due to the Fed’s policy measures to control inflation wreaked havoc on the stock market over the past few weeks. However, the recovery of the major stock-market...

AMGN : 249.04 (+0.62%)
V : 207.56 (+4.29%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 146.53 (+0.48%)
AMGN : 249.04 (+0.62%)
GILD : 63.66 (-0.28%)
VRTX : 268.35 (+3.77%)
IBB : 116.44 (+0.72%)
XBI : 70.14 (-0.27%)
BridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor

BridgeBio (BBIO) forms an exclusive partnership with Bristol Myers (BMY) to develop and commercialize its SHP2 inhibitor.

BMY : 76.70 (+0.67%)
AMGN : 249.04 (+0.62%)
ALKS : 29.30 (-2.33%)
BBIO : 7.34 (-3.55%)
The Zacks Analyst Blog Highlights Amgen, Altria Group, Uber Technologies, Microchip Technology, and Arista Networks

Amgen, Altria Group, Uber Technologies, Microchip Technology, and Arista Networks are part of Zacks top Analyst Blog.

AMGN : 249.04 (+0.62%)
MO : 52.12 (+2.02%)
MCHP : 67.00 (+0.49%)
ANET : 102.30 (-0.33%)
UBER : 23.78 (+1.84%)
Top Research Reports for Amgen, Altria Group & Uber

Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Altria Group, Inc. (MO), and Uber Technologies, Inc. (UBER).

WMB : 36.02 (+1.81%)
AMGN : 249.04 (+0.62%)
MO : 52.12 (+2.02%)
MCHP : 67.00 (+0.49%)
ANET : 102.30 (-0.33%)
UBER : 23.78 (+1.84%)
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?

Sector ETF report for PJP

PJP : 74.74 (+0.62%)
JNJ : 179.44 (+1.39%)
LLY : 302.60 (+1.25%)
AMGN : 249.04 (+0.62%)
IHE : 192.37 (+0.45%)
PPH : 78.54 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 253.94
2nd Resistance Point 252.49
1st Resistance Point 250.77
Last Price 249.04
1st Support Level 247.60
2nd Support Level 246.15
3rd Support Level 244.43

See More

52-Week High 258.45
Last Price 249.04
Fibonacci 61.8% 235.60
Fibonacci 50% 228.55
Fibonacci 38.2% 221.49
52-Week Low 198.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar